2.10
Precedente Chiudi:
$2.06
Aprire:
$2.05
Volume 24 ore:
3,199
Relative Volume:
0.25
Capitalizzazione di mercato:
$14.74M
Reddito:
$1.34M
Utile/perdita netta:
$-13.49M
Rapporto P/E:
-0.1692
EPS:
-12.4093
Flusso di cassa netto:
$-3.07M
1 W Prestazione:
-5.83%
1M Prestazione:
-4.98%
6M Prestazione:
-19.23%
1 anno Prestazione:
-73.88%
Vyome Holdings Inc Stock (HIND) Company Profile
Nome
Vyome Holdings Inc
Settore
Industria
Telefono
949-429-6680
Indirizzo
1001 CALLE AMANECER, SAN CLEMENTE
Compare HIND vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
HIND
Vyome Holdings Inc
|
2.10 | 14.46M | 1.34M | -13.49M | -3.07M | -12.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vyome Holdings Inc Borsa (HIND) Ultime notizie
Vyome Holdings, Inc. (NASDAQ: HIND) Share Price, HIND Stock News, HIND Share Price & Updates - Kalkine
Price to earnings forward of Vyome Holdings, Inc. – GETTEX:H1O - TradingView
Vyome Holdings CFO Leonard Jerry Listed in Latest SEC Insider Filing - Kalkine Media
Vyome Holdings Appoints Consulting CFO Jerry Leonard - The Globe and Mail
Vyome Holdings, Inc. Appoints Jerry Leonard as Principal Financial Officer and Principal Accounting Officer, Effective September 1, 2026 - marketscreener.com
Vyome Holdings (HIND) advances VT-1953, carries no debt - stocktitan.net
Vyome's wound gel reduced bad odor and improved lesion pain in statistically significant Phase 2 data - Stock Titan
Vyome Reports $720,000 Second-Quarter Net Loss as VT-1953 Program Advances - quiverquant.com
Vyome (HIND) Move: Records a 1.77% Increase to $2.31 on the Day; the Near-Term Reference Band Stretches From $2.19 to $2.43 in the Current UpdateSuperTrend - vinanet.vn
HIND Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 48.4% EPS BeatForward EPS Estimate - vinanet.vn
Vyome Holdings (HIND) Advances 0.93% to $2.18, Approaching Resistance at $2.29Wyckoff Accumulation - vinanet.vn
VYOME HOLDINGS ($HIND) Releases Q2 2026 Earnings - Quiver Quantitative
Vyome Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vyome Holdings (HIND) Edges Lower: Stock Testing Support Near $2.11KAMA Signal - Vinanet
Vyome Holdings (HIND) posts higher H1 2026 loss as R&D spending grows - Stock Titan
Vyome Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Vyome Holdings Ord Shs (HIND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vyome Holdings Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
HIND Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SentimentEPS Surprise History - vinanet.vn
HIND Q2'26 Earnings: EPS estimate is (0.19) USD - TradingView
Vyome Holdings, Inc. Revenue Breakdown – NASDAQ:HIND - TradingView
Vyome Holdings (HIND) Slides 2.37%: Support and Resistance Levels in FocusSafe Entry Stocks - dars.gov.et
HIND|Vyome Holdings Ord Shs|Price:2.060|Chg%:-0.080 - TradingKey
HIND|Vyome Holdings Ord Shs|Price:1.990|Chg%:-0.010 - TradingKey
Vyome Holdings (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesWeak Earnings Momentum - vinanet.vn
HIND Q1 2026 Earnings: Bottom-Line Beat Drives Sentiment Amid Absence of Revenue DetailsEarnings Decline Risk - vinanet.vn
Price to sales forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
HIND Q1 2026 Earnings: EPS Beat Estimates as Cost Management Drives SurpriseEarnings Analysis - vinanet.vn
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrower Loss Beats Expectations Amid Weak Revenue DisclosureEPS Growth Rate - dars.gov.et
HIND Q1 2026 Earnings: Positive EPS Surprise Fails to Lift Shares Amid Revenue Uncertainty - vinanet.vn
HIND Q1 2026 Earnings: EPS Beat Despite Negative Earnings; Stock Slips 2.68%Guidance Revision Trend - vinanet.vn
Vyome (HIND) Proxy Filing Summary - Quartr
Vyome Holdings (HIND) Edges Lower Amid Consolidation Near Key SupportUnusual Call Volume - vinanet.vn
Vyome (HIND) Proxy filing Summary - Quartr
Vyome (HIND) Q4 2025 earnings summary - Quartr
Vyome (HIND) Q3 2025 earnings summary - Quartr
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrowing Losses Boost Investor ConfidenceRevenue Beat Analysis - dars.gov.et
Vyome Holdings (HIND) Slides 3.2% as Shares Test Key Support ZoneValue ETF - dars.gov.et
HIND Q1 2026 Earnings: Surprise EPS Beat Amidst No Revenue, Stock DeclinesEarnings Season Outlook - po-news-eg.net
Price to book forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: EPS Surprise Beats Street EstimatesEPS Consistency Score - dars.gov.et
HIND Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherEPS Miss Report - DonanımHaber
Enterprise value to EBITDA forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome receives Chinese patent for acne treatment formulation - Investing.com
Vyome receives Chinese patent for acne treatment formulation By Investing.com - Investing.com Canada
Enterprise value to revenue forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Number of shareholders of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome Holdings, Inc. Actuals & Estimates (NASDAQ:HIND) - TradingView
HIND Forecast — Price Target — Prediction for 2027 - TradingView
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift StockEPS Consistency Score - dars.gov.et
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN
Vyome Holdings Inc Azioni (HIND) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):